Plain-English translation of NCT06527612 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether exercise training can help people with fibrosing interstitial lung disease—a condition where lung tissue becomes scarred and stiff—feel better and stay healthier longer. Half of the participants will receive a structured exercise program along with their usual medical treatment, while the other half will receive written information about staying active. Researchers will follow everyone for one year to see how exercise affects symptoms, lung function, and overall quality of life.
People with scarring lung disease often feel short of breath and limited in what they can do. While medications help slow the disease, doctors aren't sure whether adding exercise training could provide additional benefits—either by improving how people feel day-to-day or by slowing how fast the disease progresses.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have an initial visit at the hospital for testing and measurements. Then you'll be randomly assigned to either the exercise group or the information group. If assigned to exercise, you'll attend one in-person training session at the hospital, then do three 30-minute exercise sessions per week at home using provided videos—with check-ins via WhatsApp. Everyone will return to the hospital for follow-up visits at 3, 6, and 12 months to see how you're doing. The whole study lasts one year.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)